GlaxoSmithKline Biologicals S.A.
Records under this name other than the patents GlaxoSmithKline Biologicals S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 294 patents it holds.
Back to GlaxoSmithKline Biologicals S.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,946,437 | Closure System for a Vial, Vial, Method of Closing and Filling a Vial and Stand for a Vial now held by Aseptic Technologies S.A. In force · High confidence | In force | High confidence | |
| US 9,101,560 | Escherichia Coli Immunogens with Improved Solubility now held by Novartis AG In force · Medium confidence | In force | Medium confidence | |
| US 9,480,735 | Novel Compositions and Methods now held by Glaxo Group Limited In force · Medium confidence | In force | Medium confidence | |
| US 10,286,053 | Novel Compositions and Methods now held by Glaxo Group Limited In force · Low confidence | In force | Low confidence | |
| US 9,572,884 | Adjuvanting Meningococcal Factor H Binding Protein now held by Novartis AG In force · Medium confidence | In force | Medium confidence | |
| US 9,315,556 | Novel Compositions and Methods now held by Glaxo Group Limited In force · High confidence | In force | High confidence | |
| US 10,398,771 | Process for Producing Influenza Vaccine In force · Low confidence | In force | Low confidence | |
| US 9,458,229 | Immunogenic Proteins and Compositions now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 10,058,600 | Detoxified Escherichia Coli Immunogens now held by Novartis AG In force · Medium confidence | In force | Medium confidence | |
| US 9,526,777 | Methods for the Induction of Ebola Virus-Specific Immune Responses Comprising Administering a Replication-Defective Chimpanzee Adenovirus Vector Expressing the Ebola Virus Glycoprotein. now held by Sabin Vaccine Institute In force · High confidence | In force | High confidence |